Searchable abstracts of presentations at key conferences in endocrinology

ea0019p282 | Reproduction | SFEBES2009

Clot structure and fibrinolysis in individuals with polycystic ovary syndrome: the effects of metformin, orlistat and pioglitazone treatment

Ajjan R , Chow L , Scott E , Carter A , Phoenix F , Grant P , Atkin S

Polycystic ovary syndrome (PCOS), which affects 7% of the female population, is associated with established cardiovascular risk factors including obesity, dyslipidaemia and insulin resistance. Thrombus formation represents the final step in the atherothrombotic process and clot structure has been shown to predict the predisposition to cardiovascular events. The aim of the present work was to assess the effects of commonly used therapeutic agents on clot structure and fibrinoly...

ea0004oc13 | Endocrine tumours and neoplasia | SFE2002

Expression of insulin-like growth factor binding protein-3(IGFBP-3) is down regulated in breast cancer compared to normal breast tissue

McCarthy K , Laban C , Bustin S , Ogunkolade B , Carpenter R , Jenkins P

Background: Recent studies have suggested that an increased level of serum IGF-1 and a decreased level of IGFBP-3 may be associated with an increased risk of developing subsequent breast cancer. However, it is uncertain whether these effects are mediated solely by endocrine actions or whether local effects might also be important. We have previously demonstrated IGF-1 mRNA to be universally expressed in normal breast tissue but in only 50% of cancers. The expression of IGFBP-3...

ea0029p1511 | Pituitary Clinical | ICEECE2012

Macroprolactin levels in healthy blood donors

Horvath D. , Locsei Z. , Catomio C. , Jager R. , Hadarits F. , Kovacs G. , Toldy E.

The incidence of macroprolactinemia decreased notably because of wide use of prolactin (PRL) assays measuring macroprolactin at a lower rate. However, in case of high PRL levels, measurement of monomeric PRL (mPRL) levels after polyethylene glycol (PEG) treatment is still required. Our aim was to determine – by the use of a second generation PRL assay – how total PRL (tPRL) levels in native sera of healthy blood donors change after PEG treatment. In women, the use of...

ea0003p80 | Cytokines and Growth Factors | BES2002

Growth hormone treatment does not decrease homocysteine levels

Lewandowski K , Murray R , Drzewoski J , Czupryniak L , Hillhouse E , Shalet S , Randeva H

Growth hormone (GH) deficiency is associated with insulin insensitivity, abnormalities of endothelial function and increased cardiovascular mortality. Hyperhomocysteinaemia is also associated with impaired endothelial function, and it has been established as a risk factor for cardiovascular disease. GH treatment improves lipid profile and endothelial function, but it is not known whether it can affect homocysteine levels.Material & Methods: Twenty-t...

ea0063p203 | Diabetes, Obesity and Metabolism 1 | ECE2019

Does osteocalcin have a role in Turkish gestational diabetes mellitus and its subgroups

Koc Gonul , Gursoy Gul , Halis Besime , Eksiler Hanife Copur , Yıldırım Ahmet , Gorar Suheyla , Culha Cavit , Aral Yalcın

Background: Osteocalcin (Ost) is an osteoblast derived protein locally acting on bone formation. Ost could also have a role in regulation of glucose and fat metabolism. It has been shown that Ost can directly stimulate proliferation of β cells and have effect on secreting insulin, and can act on insulin sensitivity by cytokines. It was not fully investigated in gestational diabetes mellitus. The aim of our study was to investigate osteocalcin in Turkish gestational diabet...

ea0029p1223 | Obesity | ICEECE2012

Effect of obesity on vitamin d and parathormone levels

Baser H. , Tuzun D. , Saglam F. , Caner S. , Ersoy R. , Cakir B.

Aim: In this study our aim was to investigate the relationship between obesity and vitamin D and hyperparathyroidism.Material and Method: 127 healthy persons included in this study. Study group were divided into four groups according to body mass index (BMI). Group 1 (n=35) BMI 18.5–24.9 kg/m2, Group 2 (n=35) BMI 25–29.9 kg/m2, Group 3 (n=35) BMI 3.0–34.9 kg/m2, Group 4 (n=22) BM...

ea0017p50 | (1) | BSPED2008

Influence of body mass index and inherited insulin sensitivity on the age of diagnosis and autoantibody status in childhood Type 1 diabetes

Howey C , O'Sullivan J , Ram R , Iyer S , Leech N , Cheetham T

Introduction: The incidence of Type 1 diabetes (T1D) is rising. The effect of increasing BMI in children has been proposed. A relationship between age of diagnosis of T1D and BMI SDS has been reported by some but not confirmed in all studies. We propose age of diagnosis and autoantibody status may be influenced by BMI and inherited factors relating to BMI and insulin resistance.Methods: BMI SDS was calculated in 230 children with newly diagnosed T1D, 4&#...

ea0012p38 | Diabetes, metabolism and cardiovascular | SFE2006

Relationship between insulin resistance and adipokines with body composition and glucose tolerance

Khan FS , Islam S , Min Y , Swaminathan R , Tait S , Lowy C

ObjectiveTo examine the relationship between leptin, adiponectin and insulin resistance in a group of men and women with varying degrees of glucose tolerance and obesity.Method69 participants were investigated and divided into four groups: 15 normal weight with normal glucose tolerance (NW NGT); 22 overweight with normal glucose tolerance (OW NGT); 15 overweight with impaired glucose tolerance (OW IGT); and 1...

ea0003p181 | Neuroendocrinology | BES2002

Gender differences in the relationship between leptin and the autonomic nervous system

Flanagan D , Vaile J , Petley G , Moore V , Godsland I , Cockington R , Robinson J , Phillips D

Leptin is a crucial hormone in the regulation of body weight. It is produced by adipose tissue and acts centrally decreasing appetite and increasing energy expenditure. Leptin has been shown to stimulate sympathetic nervous system activity in vitro although the physiological relevance of this remains unclear. Increased sympathetic nervous system (SNS) activity has been implicated in the pathogenesis of insulin resistance and a greatly increased cardiovascular risk. We have the...

ea0029oc17.5 | Diabetes Basic | ICEECE2012

Glucocorticoid receptor α expression is downregulated in gluteal subcutaneous adipose tissue of black South African women and associates with increased metabolic risk

Goedecke J. , Stimson R. , Livingstone D. , Hayes P. , Adams K. , Dave J. , Keswell D. , Evans J. , Victor H. , Lambert E. , Levitt N. , Kahn S. , Olsson T.

Introduction: Increased capacity for glucocorticoid regeneration in subcutaneous adipose tissue (SAT) by 11β-hydroxysteroid dehydrogenase-1 (11HSD1) is associated with obesity and associated risk factors. We hypothesised that down-regulation of SAT 11HSD1 and/or glucocorticoid receptor-α (GRα) may explain differences in body fat distribution and metabolic risk between black and white women. The study aimed to compare the expression of 11HSD1 and glucocorticoid r...